title: Alzheimer’s disease: the new promise.
authors: Department of Medicine and Department of Neurobiology, Duke University Medical Center, Durham, North Carolina, USA. warren@neuro.duke.edu
authors: Warren J
authors: WJ
authors: Strittmatter
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000633:toxicity*; D000818:Animals; D001921:Brain / Q000378:metabolism*; D003072:Cognition Disorders / Q000209:etiology*; D000077270:Exenatide; D005260:Female; D006624:Hippocampus / Q000187:drug effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000502:physiology*; D055504:Insulin Receptor Substrate Proteins / Q000378:metabolism* / Q000502:physiology*; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D014688:Venoms / Q000627:therapeutic use*
chemical_list: D016229:Amyloid beta-Peptides; D007004:Hypoglycemic Agents; C526292:IRS1 protein, human; D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; D010455:Peptides; D014688:Venoms; D007334:Insulin-Like Growth Factor I; D000077270:Exenatide